Janssen COVID-19 vaccine tolerated in 10 patients with confirmed polyethylene glycol allergy

Maria A. Bruusgaard-Mouritsen; Grace Koo; Anne Sophie Heinrichsen; Birgitte Bech Melchiors; Matthew S. Krantz; Jessica H. Plager; Mitchell Boxer; Elizabeth J. Phillips; Cosby A. Stone; Lene H. Garvey

doi:10.1016/j.jaip.2021.12.025

Janssen COVID-19 vaccine tolerated in 10 patients with confirmed polyethylene glycol allergy

Maria A. Bruusgaard-Mouritsen, Grace Koo, Anne Sophie Heinrichsen, Birgitte Bech Melchiors, Matthew S. Krantz, Jessica H. Plager, Mitchell Boxer, Elizabeth J. Phillips, Cosby A. Stone, Lene H. Garvey^*

^*Corresponding author for this work

Research output: Contribution to journal › Journal article › Research › peer-review

11 Citations (Scopus)

Original language	English
Journal	Journal of Allergy and Clinical Immunology: In Practice
Volume	10
Issue number	3
Pages (from-to)	859-862
ISSN	2213-2198
DOIs	https://doi.org/10.1016/j.jaip.2021.12.025
Publication status	Published - 2022

Access to Document

10.1016/j.jaip.2021.12.025

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8719916/pdf/main.pdfLicence: Other

Cite this

Bruusgaard-Mouritsen, M. A., Koo, G., Heinrichsen, A. S., Melchiors, B. B., Krantz, M. S., Plager, J. H., Boxer, M., Phillips, E. J., Stone, C. A., & Garvey, L. H. (2022). Janssen COVID-19 vaccine tolerated in 10 patients with confirmed polyethylene glycol allergy. Journal of Allergy and Clinical Immunology: In Practice, 10(3), 859-862. https://doi.org/10.1016/j.jaip.2021.12.025

@article{a91ed7a363414485abae93fc80c19dd3,

title = "Janssen COVID-19 vaccine tolerated in 10 patients with confirmed polyethylene glycol allergy",

author = "Bruusgaard-Mouritsen, {Maria A.} and Grace Koo and Heinrichsen, {Anne Sophie} and Melchiors, {Birgitte Bech} and Krantz, {Matthew S.} and Plager, {Jessica H.} and Mitchell Boxer and Phillips, {Elizabeth J.} and Stone, {Cosby A.} and Garvey, {Lene H.}",

note = "Funding Information: C.A.S. receives funding from the Agency for Healthcare Research and Quality/Patient-Centered Outcomes Research Institute (grant no. 1K12HS026395-01) and the American Academy of Allergy, Asthma & Immunology Foundation. E.G.P. reports direct support as a principal investigator from the National Institutes of Health (NIH; grant nos. R01HG010863, R01AI152183, U01AI154659, UAI109565, and R13AR078623) as well as other coinvestigator support from the NIH and the National Health and Medical Research Foundation of Australia. Funding Information: C.A.S. receives funding from the Agency for Healthcare Research and Quality/ Patient-Centered Outcomes Research Institute (grant no. 1K12HS026395-01 ) and the American Academy of Allergy, Asthma & Immunology Foundation . E.G.P. reports direct support as a principal investigator from the National Institutes of Health (NIH; grant nos. R01HG010863 , R01AI152183 , U01AI154659 , UAI109565 , and R13AR078623 ) as well as other coinvestigator support from the NIH and the National Health and Medical Research Foundation of Australia . ",

year = "2022",

doi = "10.1016/j.jaip.2021.12.025",

language = "English",

volume = "10",

pages = "859--862",

journal = "Journal of Allergy and Clinical Immunology: In Practice",

issn = "2213-2198",

publisher = "Elsevier",

number = "3",

}

TY - JOUR

T1 - Janssen COVID-19 vaccine tolerated in 10 patients with confirmed polyethylene glycol allergy

AU - Bruusgaard-Mouritsen, Maria A.

AU - Koo, Grace

AU - Heinrichsen, Anne Sophie

AU - Melchiors, Birgitte Bech

AU - Krantz, Matthew S.

AU - Plager, Jessica H.

AU - Boxer, Mitchell

AU - Phillips, Elizabeth J.

AU - Stone, Cosby A.

AU - Garvey, Lene H.

N1 - Funding Information: C.A.S. receives funding from the Agency for Healthcare Research and Quality/Patient-Centered Outcomes Research Institute (grant no. 1K12HS026395-01) and the American Academy of Allergy, Asthma & Immunology Foundation. E.G.P. reports direct support as a principal investigator from the National Institutes of Health (NIH; grant nos. R01HG010863, R01AI152183, U01AI154659, UAI109565, and R13AR078623) as well as other coinvestigator support from the NIH and the National Health and Medical Research Foundation of Australia. Funding Information: C.A.S. receives funding from the Agency for Healthcare Research and Quality/ Patient-Centered Outcomes Research Institute (grant no. 1K12HS026395-01 ) and the American Academy of Allergy, Asthma & Immunology Foundation . E.G.P. reports direct support as a principal investigator from the National Institutes of Health (NIH; grant nos. R01HG010863 , R01AI152183 , U01AI154659 , UAI109565 , and R13AR078623 ) as well as other coinvestigator support from the NIH and the National Health and Medical Research Foundation of Australia .

PY - 2022

Y1 - 2022

U2 - 10.1016/j.jaip.2021.12.025

DO - 10.1016/j.jaip.2021.12.025

M3 - Journal article

C2 - 34979336

AN - SCOPUS:85123076241

SN - 2213-2198

VL - 10

SP - 859

EP - 862

JO - Journal of Allergy and Clinical Immunology: In Practice

JF - Journal of Allergy and Clinical Immunology: In Practice

IS - 3

ER -